Science and Technology Science and Technology
Thu, July 7, 2011
Wed, July 6, 2011
[ Wed, Jul 06th 2011 ] - Market Wire
AT&T Invests in Louisiana
[ Wed, Jul 06th 2011 ] - Market Wire
Larry Renfro Named CEO of Optum

OSI Systems Launches New Products in Diagnostic Cardiology


Published on 2011-07-06 13:25:37 - Market Wire
  Print publication without navigation


HAWTHORNE, Calif.--([ BUSINESS WIRE ])--[ OSI Systems, Inc. ] (NASDAQ:OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, launched Pathfinder SL, a Holter analysis solution that delivers innovative technology, rapid analysis and enhanced accuracy in the exploration of a patienta™s cardiac condition. The company also introduced Sentinel 8, the latest version of Spacelabs Healthcarea™s Cardiology Information Management System.

"With our Pathfinder SL and Sentinel 8 products, we provide doctors with compelling solutions for diagnostic cardiology and ready access to patient results and, thereby, facilitate efficient delivery of patient care."

Deepak Chopra, OSI Systems CEO, commented, aWith our Pathfinder SL and Sentinel 8 products, we provide doctors with compelling solutions for diagnostic cardiology and ready access to patient results and, thereby, facilitate efficient delivery of patient care.a

About OSI Systems, Inc.

OSI Systems, Inc. is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. We combine more than 30 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information on OSI Systems, Inc. or any of its subsidiary companies, visit [ www.osi-systems.com ]. News Filter: OSIS-G

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the company's expectations, goals or intentions about the future, including, the Company's contracts to deliver a broad range of solutions to customers in the healthcare industry.The actual results may differ materially from those described in or implied by any forward-looking statement.